Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

National Taiwan University Hospital (2)

Hoffmann-La Roche (1)

Collaborator

Intervention

pralsetinib (blu-667) (1)

thyroid and parathyroid disease (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

thyroid diseases

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting

RET-altered Non Small Cell Lung Cancer
+39 more

pralsetinib (BLU-667)

Phoenix, Arizona
+65 more

Nov 10, 2022

Autoimmune Thyroid Heart Disease Via Urinary Exosomal Proteins

Completed

Thyroid Diseases
Heart Failure

Taipei, Taiwan

National Taiwan University Hospital

Sep 1, 2021

The Analysis of Thyroidectomy and Parathyroidectomy

Recruiting

Thyroid Diseases
Parathyroid Diseases

Thyroid and parathyroid disease

Taipei, Taiwan

Ting-Chun Kuo

Jun 8, 2021